Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors

NCT02789228 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT02789228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02789228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors
Lead sponsor
Children's National Research Institute
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 12, 2016
Completion date
December 31, 2027
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors